CIK 0001266806 · Non-accelerated filer<br>Smaller reporting company
Vivani Medical, Inc.
Sign in to watch- Ticker
- VANI
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 020692322
- Phone
- 415-506-8462
- Business address
- 1350 S. LOOP ROAD, ALAMEDA, CA, 94502
- Former names
- SECOND SIGHT MEDICAL PRODUCTS INC, SECOUND SIGHT MEDICAL PRODUCTS INC
- Open-market buys, last 90 days
- $19,645
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$19,645. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-20 | McGuire Jonathan Will Chief Executive Officer | Sale | −1,793 | $5.44 | $10K | 23,826 |
| 2020-02-20 | Blake John T Chief Financial Officer | Returned to the company | −809 | $5.44 | $4K | 1,754 |
| 2020-02-19 | RYAN WILLIAM PATRICK Chief Operating Officer | Grant or award | +3,594 | 3,594 | ||
| 2020-02-19 | RYAN WILLIAM PATRICK Chief Operating Officer | Option exercise · Restricted Stock Units(RSUs) | −3,594 | 10,781 | ||
| 2020-02-19 | McGuire Jonathan Will Chief Executive Officer | Grant or award | +5,532 | 25,619 | ||
| 2020-02-19 | McGuire Jonathan Will Chief Executive Officer | Option exercise · Restricted Stock Units (RSUs) | −5,532 | 16,593 | ||
| 2020-02-19 | Blake John T Chief Financial Officer | Grant or award | +2,563 | 2,563 | ||
| 2020-02-19 | Blake John T Chief Financial Officer | Option exercise · Restricted Stock Units(RSUs) | −2,563 | 7,687 | ||
| 2020-02-12 | RYAN WILLIAM PATRICK Chief Operating Officer | Grant or award · Non-Qualified Stock Option(right to buy) | +28,305 | 28,305 | ||
| 2020-02-12 | McGuire Jonathan Will Chief Executive Officer | Grant or award · Non-Qualified Stock Option(right to buy) | +43,755 | 43,755 | ||
| 2020-02-12 | Dorn Jessy Dana VP-Clin & Scientific Affairs | Grant or award · Non-Qualified Stock Option(right to buy) | +8,899 | 8,899 | ||
| 2020-02-12 | Blake John T Chief Financial Officer | Grant or award · Non-Qualified Stock Option(right to buy) | +20,147 | 20,147 | ||
| 2019-12-03 | Dorn Jessy Dana VP-Clin & Scientific Affairs | Returned to the company | −7,265 | $0.81 | $6K | 1,458 |
| 2019-11-29 | Dorn Jessy Dana VP-Clin & Scientific Affairs | Grant or award | +7,265 | $0.59 | $4K | 8,723 |
| 2019-08-20 | McGuire Jonathan Will Chief Executive Officer | Sale | −3,902 | $0.81 | $3K | 142,770 |
| 2019-08-19 | McGuire Jonathan Will Chief Executive Officer | Option exercise | +11,875 | 146,672 | ||
| 2019-08-19 | McGuire Jonathan Will Chief Executive Officer | Option exercise · Restricted Stock Units (RSUs) | −11,875 | 0 | ||
| 2019-07-26 | Williams Gregg Director | Grant or award | +14,172 | $0.87 | $12K | 79,126,570 |
| 2019-07-25 | Williams Gregg Director | Grant or award | +5,470 | $0.86 | $5K | 79,112,398 |
| 2019-07-24 | Williams Gregg Director | Grant or award | +5,000 | $0.89 | $4K | 79,106,928 |
Page 16 of 20 · 397 trades